Unannounced audits signal a new, much tougher era for EU medtech sector
This article was originally published in SRA
There has been a largely negative response from the medtech industry to unannounced audits by notified bodies in the EU. But what is perspective from the other side? What is it like for notified bodies, who are under increased scrutiny from their designating authorities and under pressure to deliver far more stringent auditing of medtech manufacturers. Reporting from regulatory meetings in Brussels, Berlin and London, Amanda Maxwell provides a snapshot of the mood,
You may also be interested in...
Interview: Bassil Akra Speaks About Leaving TÜV-SÜD, Future Challenges, Opportunities And COVID-19 Realities
As Bassil Akra returned his office equipment and access card to his TÜV-SÜD offices in Munich amidst a welcome of balloons, Medtech Insight asked what this meant for him personally and what it will be like to start in consultancy during a pandemic.
EU MDR Panel Discussion: Why An Extra Year Is Not Really A Delay For The MDR – How To Survive Changing And Confusing Times
26 May 2020, the date that the Medical Device Regulation was originally due to apply in the EU, was a good time to take stock of where the medtech sector finds itself. Three of the most renowned and outspoken experts on the EU medical device regulatory system gave their views in this exclusive interview.
National authorities can renew notified body designations by conducting reviews that do not include on-site visits, overturning one of the most critical measures introduced in medical device regulations over the last seven years.